Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sana Biotechnology, Inc. - Common Stock
(NQ:
SANA
)
3.200
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sana Biotechnology, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 04, 2023
Via
Benzinga
Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System
December 01, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at November and December 2023 Investor Conferences
November 21, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes
November 17, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis
November 09, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates
November 08, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting
November 02, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Increased Focus on Hypoimmune-Related Pipeline with the Potential to Deliver Clinical Proof of Concept Data from Four Programs in 2023 and 2024 with a 2024 Operating Burn under $200M
October 10, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
↗
September 25, 2023
Via
Benzinga
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
September 13, 2023
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 13, 2023
Via
Benzinga
Sana Biotechnology to Present at September 2023 Investor Conferences
August 30, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
↗
September 05, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
↗
August 14, 2023
Via
Benzinga
Sana Biotechnology Reports Second Quarter 2023 Financial Results and Business Updates
August 03, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
3 Hidden Penny Stocks That Could Turn $100 into $10,000
↗
July 31, 2023
These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.
Via
InvestorPlace
Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023 Annual Meeting
June 16, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at June 2023 Investor Conferences
May 31, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 30, 2023
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
Via
Benzinga
Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday
↗
May 30, 2023
U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
Sana Biotechnology Announces Preclinical Data Published in Nature Biotechnology Demonstrating its Hypoimmune-Engineered Cells Escape Immune Detection and Survive While Remaining Fully Functional
May 08, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Reports First Quarter 2023 Financial Results and Business Updates
May 08, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
7 High-Potential Penny Stocks in the Biotech Sector
↗
May 04, 2023
Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider.
Via
InvestorPlace
Sana Biotechnology to Present at May 2023 Investor Conferences
May 03, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces the Acceptance of Six Abstracts for Presentation at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
May 02, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
↗
May 02, 2023
Via
Benzinga
Sana Biotechnology to Host Research & Development Day
April 24, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
The Top 3 Biotech Stocks to Watch in 2023
↗
April 20, 2023
Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023.
Via
InvestorPlace
Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with Four Presentations at the 2023 AACR Annual Meeting
April 19, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
